Evolus (NASDAQ: EOLS) insider transactions

In the twelve months to 10 November 2026, executives and directors of Evolus reported 7 open-market sales of 281,412 shares ($1.8m) and 0 open-market purchases, by 2 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Evolus shares reported on Form 4
Date	Insider	Role	Transaction	Shares	Price	Held after	Filing
2 September 2026	Moatazedi David	See Remarks	Open-market sale	−105,108	$9.04	499,592	Form 4
20 March 2026	Moatazedi David	See Remarks	Open-market sale, 10b5-1 plan	−13,669	$4.75	604,700	Form 4
20 March 2026	Avelar Rui	See Remarks	Open-market sale	−3,119	$4.75	427,423	Form 4
17 March 2026	Avelar Rui	See Remarks	Open-market sale, 10b5-1 plan	−29,996	$4.89	430,542	Form 4
17 March 2026	Moatazedi David	See Remarks	Open-market sale, 10b5-1 plan	−116,720	$4.89	618,369	Form 4
16 March 2026	Avelar Rui	See Remarks	Option exercise, 10b5-1 plan	+8,804	—	460,538	Form 4
16 March 2026	Moatazedi David	See Remarks	Option exercise, 10b5-1 plan	+67,489	—	735,089	Form 4
17 February 2026	Gill David N	Director	Grant or award	+45,559	—	86,887	Form 4
17 February 2026	Avelar Rui	See Remarks	Grant or award	+94,913	—	451,734	Form 4
17 February 2026	Malik Vikram	Director	Grant or award	+45,559	—	321,109	Form 4
17 February 2026	Moatazedi David	See Remarks	Grant or award	+313,212	—	667,600	Form 4
17 February 2026	White Albert G III	Director	Grant or award	+45,559	—	95,937	Form 4
17 February 2026	Mitchell Tatjana	Chief Financial Officer	Grant or award	+121,489	—	226,092	Form 4
17 February 2026	Stewart Brady	Director	Grant or award	+45,559	—	134,188	Form 4
17 February 2026	Parschauer Karah Herdman	Director	Grant or award	+45,559	—	77,742	Form 4
22 December 2025	Avelar Rui	See Remarks	Open-market sale, 10b5-1 plan	−2,261	$7.15	356,821	Form 4
22 December 2025	Moatazedi David	See Remarks	Open-market sale, 10b5-1 plan	−10,539	$7.15	354,388	Form 4
8 September 2025	Mitchell Tatjana	Chief Financial Officer	Grant or award	+104,603	—	104,603	Form 4
22 August 2025	Yamagishi-Dressler Tomoko	Chief Marketing Officer	Open-market sale, 10b5-1 plan	−5,722	$7.51	89,949	Form 4
15 August 2025	Stewart Brady	Director	Open-market purchase	+30,000	$6.82	88,629	Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Evolus page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.